Goldman Sachs has initiated coverage on Agilent Technologies Inc (A) with a Buy rating as of December 8, 2025. This marks the firm's first assessment of the company's investment potential, reflecting their research and analysis of Agilent's business, industry dynamics, and growth prospects.
Agilent Technologies, headquartered in Santa Clara, California, operates within the Life Sciences Tools & Services sector. The company engages in providing application-focused solutions for life sciences, diagnostics, and applied chemical markets. With a workforce of approximately 18,000 employees, Agilent's segments include Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The company offers a range of products, including active pharmaceutical ingredients and laboratory automation solutions.
As of December 4, 2025, Agilent's market capitalization stands at $41.7 billion, with a trailing twelve-month price-to-earnings ratio of 34.20 and earnings per share of 4.27. The company also boasts a dividend yield of 68.3%. Upcoming earnings reports are scheduled for February 24, 2026, and May 26, 2026, with estimated EPS of $1.40 and $1.43, respectively.
Goldman Sachs' new rating adds to a consensus of 6 Strong Buy, 10 Buy, and 10 Hold ratings among analysts, indicating a generally favorable outlook for the company. Analyst ratings can change over time as new information emerges, and it is important for investors to consider various factors, including company fundamentals and market conditions, when making decisions.